To link to the entire object, paste this link in email, IM or documentTo embed the entire object, paste this HTML in websiteTo link to this page, paste this link in email, IM or documentTo embed this page, paste this HTML in website

INTERIM STUDY REPORT
Public Health Committee
Rep. John Enns, Chairman
Oklahoma House of Representatives
Interim Study 11-03, Rep. Colby Schwartz
Sept. 27, 2011
Electronic prescribing (eRx)
Drew Duncan, director of government relations
Pfizer
• Any electronic prescribing (eRx) system should improve patient care and strengthen the
physician/patient relationship. It needs to put the patient first.
• It should provide instant information when its needed, where technology and healthcare
interact, intersect.
• Any system should reduce the overall cost of healthcare.
• Pfizer spends $6-8 billion a year on research and development with the goal of creating
new meds everyone can benefit from. Often, there are more misses than hits.
• A primary concern of Pfizer’s is the transparency of all meds. All meds should be
accessible to the physician based on personal judgment of what is best for patient.
• Another concern when looking at eRx is that patients who successfully navigate the prior
authorization process after being written a prescription should be grandfathered into any
new system and not have to go back through the process again, even if they switch
providers.
• Other states, such as FL, KS, ND and ME, have addressed eRx in varying degrees.
John Crumly, executive vice president
Pharmacy Providers of OK
Speaking on behalf of Oklahoma Pharmacists Association
jcrumly@ppok.com
• Since pharmaceutical manufacturers compete as preferred or nonpreferred on a
formulary, there originally was concern that eRx would be used as a tool to influence
physicians.
• There also is concern that it could be used to steer prescriptions to particular providers.
• Most prior authorization tools are web portal or faxed-based and not focused on e-prior
authorizations.
• Ninety percent of pharmacies in Oklahoma are prepared to do eRx now. There are 800
pharmacies in the state, so 700 should be ready.
• The 10 percent that are not ready are primarily in rural areas where some pharmacies
haven’t gotten latest software. However, some grant money is available that could help
Oklahoma get to 100 percent.
• There has been recent exponential growth in eRx. Surescripts is the conduit. In 2009,
they reported over 2 million scripts done via eRx in Oklahoma.
• In 2009, physicians in Oklahoma participated at an 18 percent rate, but that number has
likely risen dramatically because of recent CMS incentives for using technology.
• The Oklahoma doctors that are using eRx are using it a lot because the 2 million scripts
came from only the 18 percent participating.

INTERIM STUDY REPORT
Public Health Committee
Rep. John Enns, Chairman
Oklahoma House of Representatives
Interim Study 11-03, Rep. Colby Schwartz
Sept. 27, 2011
Electronic prescribing (eRx)
Drew Duncan, director of government relations
Pfizer
• Any electronic prescribing (eRx) system should improve patient care and strengthen the
physician/patient relationship. It needs to put the patient first.
• It should provide instant information when its needed, where technology and healthcare
interact, intersect.
• Any system should reduce the overall cost of healthcare.
• Pfizer spends $6-8 billion a year on research and development with the goal of creating
new meds everyone can benefit from. Often, there are more misses than hits.
• A primary concern of Pfizer’s is the transparency of all meds. All meds should be
accessible to the physician based on personal judgment of what is best for patient.
• Another concern when looking at eRx is that patients who successfully navigate the prior
authorization process after being written a prescription should be grandfathered into any
new system and not have to go back through the process again, even if they switch
providers.
• Other states, such as FL, KS, ND and ME, have addressed eRx in varying degrees.
John Crumly, executive vice president
Pharmacy Providers of OK
Speaking on behalf of Oklahoma Pharmacists Association
jcrumly@ppok.com
• Since pharmaceutical manufacturers compete as preferred or nonpreferred on a
formulary, there originally was concern that eRx would be used as a tool to influence
physicians.
• There also is concern that it could be used to steer prescriptions to particular providers.
• Most prior authorization tools are web portal or faxed-based and not focused on e-prior
authorizations.
• Ninety percent of pharmacies in Oklahoma are prepared to do eRx now. There are 800
pharmacies in the state, so 700 should be ready.
• The 10 percent that are not ready are primarily in rural areas where some pharmacies
haven’t gotten latest software. However, some grant money is available that could help
Oklahoma get to 100 percent.
• There has been recent exponential growth in eRx. Surescripts is the conduit. In 2009,
they reported over 2 million scripts done via eRx in Oklahoma.
• In 2009, physicians in Oklahoma participated at an 18 percent rate, but that number has
likely risen dramatically because of recent CMS incentives for using technology.
• The Oklahoma doctors that are using eRx are using it a lot because the 2 million scripts
came from only the 18 percent participating.